Wai-Ping Choo1, A B Johan Groeneveld2, Ronald H Driessen3, Eleonora L Swart4. 1. Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: w.choo@vumc.nl. 2. Department of Intensive Care, Erasmus Medical Center, Rotterdam, The Netherlands. 3. Department of Intensive care, VU University Medical Center, Amsterdam, The Netherlands. 4. Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
PURPOSE: We wanted to identify modifiable risk factors for intensive care unit (ICU)-acquired hypernatremia. MATERIALS AND METHODS: We retrospectively studied sodium and fluid loads and balances up to 7 days prior to the development of hypernatremia (first serum sodium concentration, [Na+], >150 mmol/L; H) vs control (maximum [Na+] ≤150 mmol/L; N), in consecutive patients admitted into the ICU with a normal serum sodium (<145 mmol/L) and without cerebral disease, within a period of 8 months. RESULTS: There were 57 H and 150 N patients. Severity of disease and organ failure was greater, and length of stay and mechanical ventilation in the ICU were longer in H (P<.001), with a mortality rate of 28% vs 16% in N (P=.002). Sodium input was higher in H than in N, particularly from 0.9% saline to dissolve drugs for infusion and to keep catheters open during the week prior to the first day of hypernatremia (P<.001). Fluid balances were positive and did not differ from N on most days in the presence of slightly higher plasma creatinine and more frequent administration of furosemide, at higher doses, in H than in N. CONCLUSIONS: High sodium input by 0.9% saline used to dilute drugs and keep catheters open is a modifiable risk factor for ICU-acquired H. Dissolving drugs in dextrose 5% may partially prevent potentially harmful sodium overloading and H.
PURPOSE: We wanted to identify modifiable risk factors for intensive care unit (ICU)-acquired hypernatremia. MATERIALS AND METHODS: We retrospectively studied sodium and fluid loads and balances up to 7 days prior to the development of hypernatremia (first serum sodium concentration, [Na+], >150 mmol/L; H) vs control (maximum [Na+] ≤150 mmol/L; N), in consecutive patients admitted into the ICU with a normal serum sodium (<145 mmol/L) and without cerebral disease, within a period of 8 months. RESULTS: There were 57 H and 150 Npatients. Severity of disease and organ failure was greater, and length of stay and mechanical ventilation in the ICU were longer in H (P<.001), with a mortality rate of 28% vs 16% in N (P=.002). Sodium input was higher in H than in N, particularly from 0.9% saline to dissolve drugs for infusion and to keep catheters open during the week prior to the first day of hypernatremia (P<.001). Fluid balances were positive and did not differ from N on most days in the presence of slightly higher plasma creatinine and more frequent administration of furosemide, at higher doses, in H than in N. CONCLUSIONS: High sodium input by 0.9% saline used to dilute drugs and keep catheters open is a modifiable risk factor for ICU-acquired H. Dissolving drugs in dextrose 5% may partially prevent potentially harmful sodium overloading and H.
Authors: Bruno Adler Maccagnan Pinheiro Besen; André Luiz Nunes Gobatto; Lívia Maria Garcia Melro; Alexandre Toledo Maciel; Marcelo Park Journal: World J Crit Care Med Date: 2015-05-04
Authors: Marjolein van IJzendoorn; Linda de Vries; Jacob van den Born; Hanneke Buter; Gerjan Navis; Christiaan Boerma Journal: J Transl Int Med Date: 2020-09-25
Authors: Annemieke Oude Lansink-Hartgring; Lara Hessels; Joachim Weigel; Anne Marie G A de Smet; Diederik Gommers; Prashant V Nannan Panday; Ewout J Hoorn; Maarten W Nijsten Journal: Ann Intensive Care Date: 2016-03-17 Impact factor: 6.925
Authors: Manu L N G Malbrain; Thomas Langer; Djillali Annane; Luciano Gattinoni; Paul Elbers; Robert G Hahn; Inneke De Laet; Andrea Minini; Adrian Wong; Can Ince; David Muckart; Monty Mythen; Pietro Caironi; Niels Van Regenmortel Journal: Ann Intensive Care Date: 2020-05-24 Impact factor: 6.925
Authors: Niels Van Regenmortel; Lynn Moers; Thomas Langer; Ella Roelant; Tim De Weerdt; Pietro Caironi; Manu L N G Malbrain; Paul Elbers; Tim Van den Wyngaert; Philippe G Jorens Journal: Ann Intensive Care Date: 2021-05-17 Impact factor: 6.925
Authors: Thomas Langer; Veronica D'Oria; Giulia C I Spolidoro; Giovanna Chidini; Stefano Scalia Catenacci; Tiziana Marchesi; Marta Guerrini; Andrea Cislaghi; Carlo Agostoni; Antonio Pesenti; Edoardo Calderini Journal: BMC Pediatr Date: 2020-09-05 Impact factor: 2.125